— ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform of CD24 (neoCD24) ...
Today calls for caution in your interactions, as conversations might carry more weight than usual. Hold off on revealing...
NIFTY continues to consolidate within the zone of a potential bearish breakout, with price still ranging around a key re...
Mumbai witnessed the final chapter of Air India’s legacy as the iconic Nariman Point building was sold to the Maharash...
Beijing Summit Go For Service Boost Amidst Geopolitical Tensions Beijing organized a high-stakes summit today, seeking t...
Screenshot The battle for control of the U.S. House is increasingly being fought not just at the ballot box but in the m...
Firstsource Solutions Ltd's Board of Directors approved the audited standalone and consolidated financial results for th...
Saudi Arabia’s energy giant Aramco is best known for its energy investments, but the company is also busy diversifying...
New institute will consolidate SMU's ageing-related research and drive an interdisciplinary agenda to build resilient an...
NotebookLM has become a versatile platform for research and organization, combining efficiency with adaptability. Accord...